BACKGROUND: The Dietary Approaches to Stop Hypertension (DASH) dietary pattern, which emphasizes fruit, vegetables, fat-free/low-fat dairy, whole grains, nuts and legumes, and limits saturated fat, cholesterol, red and processed meats, sweets, added sugars, salt and sugar-sweetened beverages, is widely recommended by international diabetes and heart association guidelines. OBJECTIVE: To summarize the available evidence for the update of the European Association of the Study of Diabetes (EASD) guidelines, we conducted an umbrella review of existing systematic reviews and meta-analyses using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach of the relation of the DASH dietary pattern with cardiovascular disease and other cardiometabolic outcomes in prospective cohort studies and its effect on blood pressure and other cardiometabolic risk factors in controlled trials in individuals with and without diabetes. METHODS: MEDLINE and EMBASE were searched through 3 January 2019. We included systematic reviews and meta-analyses assessing the relation of the DASH dietary pattern with cardiometabolic disease outcomes in prospective cohort studies and the effect on cardiometabolic risk factors in randomized and non-randomized controlled trials. Two independent reviewers extracted relevant data and assessed the risk of bias of individual studies. The primary outcome was incident cardiovascular disease (CVD) in the prospective cohort studies and systolic blood pressure in the controlled trials. Secondary outcomes included incident coronary heart disease, stroke, and diabetes in prospective cohort studies and other established cardiometabolic risk factors in controlled trials. If the search did not identify an existing systematic review and meta-analysis on a pre-specified outcome, then we conducted our own systematic review and meta-analysis. The evidence was summarized as risk ratios (RR) for disease incidence outcomes and mean differences (MDs) for risk factor outcomes with 95% confidence intervals (95% CIs). The certainty of the evidence was assessed using GRADE. RESULTS: We identified three systematic reviews and meta-analyses of 15 unique prospective cohort studies (n = 942,140) and four systematic reviews and meta-analyses of 31 unique controlled trials (n = 4,414) across outcomes. We conducted our own systematic review and meta-analysis of 2 controlled trials (n = 65) for HbA1c. The DASH dietary pattern was associated with decreased incident cardiovascular disease (RR, 0.80 (0.76⁻0.85)), coronary heart disease (0.79 (0.71⁻0.88)), stroke (0.81 (0.72⁻0.92)), and diabetes (0.82 (0.74⁻0.92)) in prospective cohort studies and decreased systolic (MD, -5.2 mmHg (95% CI, -7.0 to -3.4)) and diastolic (-2.60 mmHg (-3.50 to -1.70)) blood pressure, Total-C (-0.20 mmol/L (-0.31 to -0.10)), LDL-C (-0.10 mmol/L (-0.20 to -0.01)), HbA1c (-0.53% (-0.62, -0.43)), fasting blood insulin (-0.15 μU/mL (-0.22 to -0.08)), and body weight (-1.42 kg (-2.03 to -0.82)) in controlled trials. There was no effect on HDL-C, triglycerides, fasting blood glucose, HOMA-IR, or CRP. The certainty of the evidence was moderate for SBP and low for CVD incidence and ranged from very low to moderate for the secondary outcomes. CONCLUSIONS: Current evidence allows for the conclusion that the DASH dietary pattern is associated with decreased incidence of cardiovascular disease and improves blood pressure with evidence of other cardiometabolic advantages in people with and without diabetes. More research is needed to improve the certainty of the estimates.

CIBER Fisiopatología de la Obesidad y Nutrición Instituto de Salud Carlos 3 Madrid 28029 Spain

College of Pharmacy and Nutrition University of Saskatchewan Saskatoon SK S7N 2Z4 Canada

Department of Endocrinology Diabetes and Clinical Pharmacology Dubrava University Hospital 10000 Zagreb Croatia

Department of Nutritional Sciences Faculty of Medicine University of Toronto Toronto ON M5S 1A8 Canada

Division of Endocrinology and Metabolism St Michael's Hospital Toronto Ontario M5C 2T2 Canada

Human Nutrition Unit Biochemistry and Biotechnology Department Hospital Universitari de Sant Joan de Reus IISPV Universitat Rovira i Virgili Reus 43201 Spain

Institute for Clinical and Experimental Medicine Diabetes Centre 140 21 Prague Czech Republic

Li Ka Shing Knowledge Institute St Michael's Hospital Toronto ON M5C 2T2 Canada

Physicians Committee for Responsible Medicine Washington DC 20016 4131 USA

School of Medicine University of Zagreb 10000 Zagreb Croatia

Toronto 3D Knowledge Synthesis and Clinical Trials Unit Clinical Nutrition and Risk Factor Modification Center St Michael's Hospital Toronto ON M5C 2T2 Canada

See more in PubMed

International Diabetes Federation IDF Diabetes Atlas. [(accessed on 30 January 2018)];2015 Available online: http://www.diabetesatlas.org/resources/2015-atlas.html.

O’Rourke K., VanderZanden A., Shepard D., Leach-Kemon K. Cardiovascular disease worldwide, 1990–2013. JAMA. 2015;314:1905. doi: 10.1001/jama.2015.14994. DOI

World Health Organization (WHO) Obesity. [(accessed on 30 January 2018)]; Available online: http://www.who.int/gho/ncd/riskfactors/obesity_text/en/

Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jr., Jones D.W., Materson B.J., Oparil S., Wright J.T., Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572. doi: 10.1001/jama.289.19.2560. PubMed DOI

American Heart Association Nutrition Committee. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., Franklin B., Kris-Etherton P., Harris W.S., et al. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96. doi: 10.1161/CIRCULATIONAHA.106.176158. PubMed DOI

Anderson T.J., Gregoire J., Pearson G.J., Barry A.R., Couture P., Dawes M., Francis G.A., Genest J., Jr., Grover S., Gupta M., et al. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can. J. Cardiol. 2016;32:1263–1282. doi: 10.1016/j.cjca.2016.07.510. PubMed DOI

Evert A.B., Boucher J.L., Cypress M., Dunbar S.A., Franz M.J., Mayer-Davis E.J., Neumiller J.J., Nwankwo R., Verdi C.L., Urbanski P., et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Suppl. 1):S120–S143. doi: 10.2337/dc14-S120. PubMed DOI

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Dworatzek P.D., Arcudi K., Gougeon R., Husein N., Sievenpiper J.L., Williams S.L. Nutrition therapy. Can. J. Diabetes. 2013;37(Suppl. 1):S45–S55. doi: 10.1016/j.jcjd.2013.01.019. PubMed DOI

Nerenberg K.A., Zarnke K.B., Leung A.A., Dasgupta K., Butalia S., McBrien K., Harris K.C., Nakhla M., Cloutier L., Gelfer M., et al. Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can. J. Cardiol. 2018;34:506–525. doi: 10.1016/j.cjca.2018.02.022. PubMed DOI

Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller E.R., 3rd, Simons-Morton D.G., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med. 2001;344:3–10. doi: 10.1056/NEJM200101043440101. PubMed DOI

Siervo M., Lara J., Chowdhury S., Ashor A., Oggioni C., Mathers J.C. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: A systematic review and meta-analysis. Br. J. Nutr. 2015;113:1–15. doi: 10.1017/S0007114514003341. PubMed DOI

Jannasch F., Kroger J., Schulze M.B. Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies. J. Nutr. 2017;147:1174–1182. doi: 10.3945/jn.116.242552. PubMed DOI

Schwingshackl L., Hoffmann G. Diet quality as assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension score, and health outcomes: A systematic review and meta-analysis of cohort studies. J. Acad. Nutr. Diet. 2015;115:780–800 e785. doi: 10.1016/j.jand.2014.12.009. PubMed DOI

U.S. Department of Health and Human Services and U.S. Department of Agriculture [(accessed on 27 November 2018)];2015–2020 Dietary Guidelines for Americans. (8th ed.). 2015 Dec; Available online: http://health.gov/dietaryguidelines/2015/guidelines/

Diabetes Canada Clinical Practice Guidelines Expert Committee. Sievenpiper J.L., Chan C.B., Dworatzek P.D., Freeze C., Williams S.L. Nutrition Therapy. Can. J. Diabetes. 2018;42(Suppl. 1):S64–S79. doi: 10.1016/j.jcjd.2017.10.009. PubMed DOI

Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.T., Corra U., Cosyns B., Deaton C., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur. Heart J. 2016;37:2315–2381. PubMed PMC

Eckel R.H., Jakicic J.M., Ard J.D., de Jesus J.M., Houston Miller N., Hubbard V.S., Lee I.M., Lichtenstein A.H., Loria C.M., Millen B.E., et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014;63:2960–2984. doi: 10.1016/j.jacc.2013.11.003. PubMed DOI

Higgins J.P.T., Green S. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. Cochrane Collaboration. [(accessed on 27 November 2018)]; Available online: https://handbook-5-1.cochrane.org/

Guyatt G., Oxman A.D., Akl E.A., Kunz R., Vist G., Brozek J., Norris S., Falck-Ytter Y., Glasziou P., DeBeer H., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol. 2011;64:383–394. doi: 10.1016/j.jclinepi.2010.04.026. PubMed DOI

Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int. J. Surg. 2010;8:336–341. doi: 10.1016/j.ijsu.2010.02.007. PubMed DOI

Wells G.A., Shea B., O’Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa Hospital Research Institute; Ottawa, Canada: 2014. [(accessed on 30 January 2018)]. Available online: www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

Higgins J.P., Altman D.G., Gotzsche P.C., Juni P., Moher D., Oxman A.D., Savovic J., Schulz K.F., Weeks L., Sterne J.A., et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928. PubMed DOI PMC

Balshem H., Helfand M., Schunemann H.J., Oxman A.D., Kunz R., Brozek J., Vist G.E., Falck-Ytter Y., Meerpohl J., Norris S., et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 2011;64:401–406. doi: 10.1016/j.jclinepi.2010.07.015. PubMed DOI

Brunetti M., Shemilt I., Pregno S., Vale L., Oxman A.D., Lord J., Sisk J., Ruiz F., Hill S., Guyatt G.H., et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J. Clin. Epidemiol. 2013;66:140–150. doi: 10.1016/j.jclinepi.2012.04.012. PubMed DOI

Guyatt G., Oxman A.D., Sultan S., Brozek J., Glasziou P., Alonso-Coello P., Atkins D., Kunz R., Montori V., Jaeschke R., et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J. Clin. Epidemiol. 2013;66:151–157. doi: 10.1016/j.jclinepi.2012.01.006. PubMed DOI

Guyatt G.H., Oxman A.D., Kunz R., Atkins D., Brozek J., Vist G., Alderson P., Glasziou P., Falck-Ytter Y., Schunemann H.J. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J. Clin. Epidemiol. 2011;64:395–400. doi: 10.1016/j.jclinepi.2010.09.012. PubMed DOI

Guyatt G.H., Oxman A.D., Kunz R., Brozek J., Alonso-Coello P., Rind D., Devereaux P.J., Montori V.M., Freyschuss B., Vist G., et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. J. Clin. Epidemiol. 2011;64:1283–1293. doi: 10.1016/j.jclinepi.2011.01.012. PubMed DOI

Guyatt G.H., Oxman A.D., Kunz R., Woodcock J., Brozek J., Helfand M., Alonso-Coello P., Falck-Ytter Y., Jaeschke R., Vist G., et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. J. Clin. Epidemiol. 2011;64:1303–1310. doi: 10.1016/j.jclinepi.2011.04.014. PubMed DOI

Guyatt G.H., Oxman A.D., Kunz R., Woodcock J., Brozek J., Helfand M., Alonso-Coello P., Glasziou P., Jaeschke R., Akl E.A., et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J. Clin. Epidemiol. 2011;64:1294–1302. doi: 10.1016/j.jclinepi.2011.03.017. PubMed DOI

Guyatt G.H., Oxman A.D., Montori V., Vist G., Kunz R., Brozek J., Alonso-Coello P., Djulbegovic B., Atkins D., Falck-Ytter Y., et al. GRADE guidelines: 5. Rating the quality of evidence—Publication bias. J. Clin. Epidemiol. 2011;64:1277–1282. doi: 10.1016/j.jclinepi.2011.01.011. PubMed DOI

Guyatt G.H., Oxman A.D., Santesso N., Helfand M., Vist G., Kunz R., Brozek J., Norris S., Meerpohl J., Djulbegovic B., et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J. Clin. Epidemiol. 2013;66:158–172. doi: 10.1016/j.jclinepi.2012.01.012. PubMed DOI

Guyatt G.H., Oxman A.D., Sultan S., Glasziou P., Akl E.A., Alonso-Coello P., Atkins D., Kunz R., Brozek J., Montori V., et al. GRADE guidelines: 9. Rating up the quality of evidence. J. Clin. Epidemiol. 2011;64:1311–1316. doi: 10.1016/j.jclinepi.2011.06.004. PubMed DOI

Guyatt G.H., Oxman A.D., Vist G., Kunz R., Brozek J., Alonso-Coello P., Montori V., Akl E.A., Djulbegovic B., Falck-Ytter Y., et al. GRADE guidelines: 4. Rating the quality of evidence—Study limitations (risk of bias) J. Clin. Epidemiol. 2011;64:407–415. doi: 10.1016/j.jclinepi.2010.07.017. PubMed DOI

Guyatt G.H., Thorlund K., Oxman A.D., Walter S.D., Patrick D., Furukawa T.A., Johnston B.C., Karanicolas P., Akl E.A., Vist G., et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J. Clin. Epidemiol. 2013;66:173–183. doi: 10.1016/j.jclinepi.2012.08.001. PubMed DOI

Agnoli C., Krogh V., Grioni S., Sieri S., Palli D., Masala G., Sacerdote C., Vineis P., Tumino R., Frasca G., et al. A priori-defined dietary patterns are associated with reduced risk of stroke in a large Italian cohort. J. Nutr. 2011;141:1552–1558. doi: 10.3945/jn.111.140061. PubMed DOI

Bertoia M.L., Triche E.W., Michaud D.S., Baylin A., Hogan J.W., Neuhouser M.L., Tinker L.F., Van Horn L., Waring M.E., Li W., et al. Mediterranean and Dietary Approaches to Stop Hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women. Am. J. Clin. Nutr. 2014;99:344–351. doi: 10.3945/ajcn.112.056135. PubMed DOI PMC

Fitzgerald K.C., Chiuve S.E., Buring J.E., Ridker P.M., Glynn R.J. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. J. Thromb. Haemost. 2012;10:189–198. doi: 10.1111/j.1538-7836.2011.04588.x. PubMed DOI PMC

Folsom A.R., Parker E.D., Harnack L.J. Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease. Am. J. Hypertens. 2007;20:225–232. doi: 10.1016/j.amjhyper.2006.09.003. PubMed DOI PMC

Fung T.T., Chiuve S.E., McCullough M.L., Rexrode K.M., Logroscino G., Hu F.B. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 2008;168:713–720. doi: 10.1001/archinte.168.7.713. PubMed DOI

Levitan E.B., Wolk A., Mittleman M.A. Consistency with the DASH diet and incidence of heart failure. Arch. Intern. Med. 2009;169:851–857. doi: 10.1001/archinternmed.2009.56. PubMed DOI PMC

Lin P.H., Yeh W.T., Svetkey L.P., Chuang S.Y., Chang Y.C., Wang C., Pan W.H. Dietary intakes consistent with the DASH dietary pattern reduce blood pressure increase with age and risk for stroke in a Chinese population. Asia Pac. J. Clin. Nutr. 2013;22:482–491. PubMed

Reedy J., Krebs-Smith S.M., Miller P.E., Liese A.D., Kahle L.L., Park Y., Subar A.F. Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. J. Nutr. 2014;144:881–889. doi: 10.3945/jn.113.189407. PubMed DOI PMC

Salehi-Abargouei A., Maghsoudi Z., Shirani F., Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases—incidence: A systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29:611–618. doi: 10.1016/j.nut.2012.12.018. PubMed DOI

de Koning L., Chiuve S.E., Fung T.T., Willett W.C., Rimm E.B., Hu F.B. Diet-quality scores and the risk of type 2 diabetes in men. Diabetes Care. 2011;34:1150–1156. doi: 10.2337/dc10-2352. PubMed DOI PMC

Otto M.C., Padhye N.S., Bertoni A.G., Jacobs D.R., Jr., Mozaffarian D. Everything in Moderation—Dietary Diversity and Quality, Central Obesity and Risk of Diabetes. PLoS ONE. 2015;10:e0141341. PubMed PMC

Jacobs S., Harmon B.E., Boushey C.J., Morimoto Y., Wilkens L.R., Le Marchand L., Kroger J., Schulze M.B., Kolonel L.N., Maskarinec G. A priori-defined diet quality indexes and risk of type 2 diabetes: The Multiethnic Cohort. Diabetologia. 2015;58:98–112. doi: 10.1007/s00125-014-3404-8. PubMed DOI PMC

InterAct C. Adherence to predefined dietary patterns and incident type 2 diabetes in European populations: EPIC-InterAct Study. Diabetologia. 2014;57:321–333. PubMed PMC

Liese A.D., Nichols M., Sun X., D’Agostino R.B., Jr., Haffner S.M. Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes Care. 2009;32:1434–1436. doi: 10.2337/dc09-0228. PubMed DOI PMC

Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., Bray G.A., Vogt T.M., Cutler J.A., Windhauser M.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 1997;336:1117–1124. doi: 10.1056/NEJM199704173361601. PubMed DOI

Appel L.J., Champagne C.M., Harsha D.W., Cooper L.S., Obarzanek E., Elmer P.J., Stevens V.J., Vollmer W.M., Lin P.H., Svetkey L.P., et al. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA. 2003;289:2083–2093. PubMed

Conlin P.R., Erlinger T.P., Bohannon A., Miller E.R., 3rd, Appel L.J., Svetkey L.P., Moore T.J. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Am. J. Hypertens. 2003;16:337–342. doi: 10.1016/S0895-7061(03)00056-6. PubMed DOI

Lopes H.F., Martin K.L., Nashar K., Morrow J.D., Goodfriend T.L., Egan B.M. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003;41:422–430. doi: 10.1161/01.HYP.0000053450.19998.11. PubMed DOI

Nowson C.A., Wattanapenpaiboon N., Pachett A. Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutr. Res. 2009;29:8–18. doi: 10.1016/j.nutres.2008.12.002. PubMed DOI

Nowson C.A., Worsley A., Margerison C., Jorna M.K., Frame A.G., Torres S.J., Godfrey S.J. Blood pressure response to dietary modifications in free-living individuals. J. Nutr. 2004;134:2322–2329. doi: 10.1093/jn/134.9.2322. PubMed DOI

Nowson C.A., Worsley A., Margerison C., Jorna M.K., Godfrey S.J., Booth A. Blood pressure change with weight loss is affected by diet type in men. Am. J. Clin. Nutr. 2005;81:983–989. doi: 10.1093/ajcn/81.5.983. PubMed DOI

Azadbakht L., Mirmiran P., Esmaillzadeh A., Azizi T., Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005;28:2823–2831. doi: 10.2337/diacare.28.12.2823. PubMed DOI

Azadbakht L., Surkan P.J., Esmaillzadeh A., Willett W.C. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J. Nutr. 2011;141:1083–1088. doi: 10.3945/jn.110.136739. PubMed DOI PMC

Al-Solaiman Y., Jesri A., Mountford W.K., Lackland D.T., Zhao Y., Egan B.M. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J. Hum. Hypertens. 2010;24:237–246. doi: 10.1038/jhh.2009.58. PubMed DOI PMC

Blumenthal J.A., Babyak M.A., Hinderliter A., Watkins L.L., Craighead L., Lin P.H., Caccia C., Johnson J., Waugh R., Sherwood A. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE study. Arch. Intern. Med. 2010;170:126–135. doi: 10.1001/archinternmed.2009.470. PubMed DOI PMC

Malloy-McFall J., Barkley J.E., Gordon K.L., Burzminski N., Glickman E.L. Effect of the DASH Diet on Pre- and Stage 1 Hypertensive Individuals in a Free-Living Environment. Nutr. Metab. Insights. 2010;3:15–23. doi: 10.4137/NMI.S3871. PubMed DOI PMC

Edwards K.M., Wilson K.L., Sadja J., Ziegler M.G., Mills P.J. Effects on blood pressure and autonomic nervous system function of a 12-week exercise or exercise plus DASH-diet intervention in individuals with elevated blood pressure. Acta Physiol. (Oxf.) 2011;203:343–350. doi: 10.1111/j.1748-1716.2011.02329.x. PubMed DOI PMC

Lin P.H., Allen J.D., Li Y.J., Yu M., Lien L.F., Svetkey L.P. Blood Pressure-Lowering Mechanisms of the DASH Dietary Pattern. J. Nutr. Metab. 2012;2012:472396. doi: 10.1155/2012/472396. PubMed DOI PMC

Asemi Z., Tabassi Z., Samimi M., Fahiminejad T., Esmaillzadeh A. Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: A randomised clinical trial. Br. J. Nutr. 2013;109:2024–2030. doi: 10.1017/S0007114512004242. PubMed DOI

Shirani F., Salehi-Abargouei A., Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: A systematic review and meta-analysis on controlled clinical trials. Nutrition. 2013;29:939–947. doi: 10.1016/j.nut.2012.12.021. PubMed DOI

Soltani S., Shirani F., Chitsazi M.J., Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: A systematic review and meta-analysis of randomized controlled clinical trials. Obes. Rev. 2016;17:442–454. doi: 10.1111/obr.12391. PubMed DOI

Soltani S., Chitsazi M.J., Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: A systematic review and meta-analysis of randomized trials. Clin. Nutr. 2018;37:542–550. doi: 10.1016/j.clnu.2017.02.018. PubMed DOI

Harsha D.W., Sacks F.M., Obarzanek E., Svetkey L.P., Lin P.H., Bray G.A., Aickin M., Conlin P.R., Miller E.R., 3rd, Appel L.J. Effect of dietary sodium intake on blood lipids: Results from the DASH-sodium trial. Hypertension. 2004;43:393–398. doi: 10.1161/01.HYP.0000113046.83819.a2. PubMed DOI

Chen S.T., Maruthur N.M., Appel L.J. The effect of dietary patterns on estimated coronary heart disease risk: Results from the Dietary Approaches to Stop Hypertension (DASH) trial. Circ. Cardiovasc. Qual. Outcomes. 2010;3:484–489. doi: 10.1161/CIRCOUTCOMES.109.930685. PubMed DOI PMC

Ard J.D., Grambow S.C., Liu D., Slentz C.A., Kraus W.E., Svetkey L.P., study P. The effect of the PREMIER interventions on insulin sensitivity. Diabetes Care. 2004;27:340–347. doi: 10.2337/diacare.27.2.340. PubMed DOI

Lien L.F., Brown A.J., Ard J.D., Loria C., Erlinger T.P., Feldstein A.C., Lin P.H., Champagne C.M., King A.C., McGuire H.L., et al. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension. 2007;50:609–616. doi: 10.1161/HYPERTENSIONAHA.107.089458. PubMed DOI

Al-Solaiman Y., Jesri A., Zhao Y., Morrow J.D., Egan B.M. Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J. Hum. Hypertens. 2009;23:826–835. doi: 10.1038/jhh.2009.32. PubMed DOI PMC

Hodson L., Harnden K.E., Roberts R., Dennis A.L., Frayn K.N. Does the DASH diet lower blood pressure by altering peripheral vascular function? J. Hum. Hypertens. 2010;24:312–319. doi: 10.1038/jhh.2009.65. PubMed DOI

Ard J.D., Coffman C.J., Lin P.H., Svetkey L.P. One-year follow-up study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium participants. Am. J. Hypertens. 2004;17:1156–1162. doi: 10.1016/j.amjhyper.2004.07.005. PubMed DOI

Elmer P.J., Obarzanek E., Vollmer W.M., Simons-Morton D., Stevens V.J., Young D.R., Lin P.H., Champagne C., Harsha D.W., Svetkey L.P., et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann. Intern. Med. 2006;144:485–495. doi: 10.7326/0003-4819-144-7-200604040-00007. PubMed DOI

Lima S.T., da Silva Nalin de Souza B., Franca A.K., Salgado Filho N., Sichieri R. Dietary approach to hypertension based on low glycaemic index and principles of DASH (Dietary Approaches to Stop Hypertension): A randomised trial in a primary care service. Br. J. Nutr. 2013;110:1472–1479. doi: 10.1017/S0007114513000718. PubMed DOI

Rifai L., Pisano C., Hayden J., Sulo S., Silver M.A. Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure. Bayl. Univ. Med. Cent. Proc. 2015;28:151–156. doi: 10.1080/08998280.2015.11929216. PubMed DOI PMC

Asemi Z., Samimi M., Tabassi Z., Esmaillzadeh A. The effect of DASH diet on pregnancy outcomes in gestational diabetes: A randomized controlled clinical trial. Eur. J. Clin. Nutr. 2014;68:490–495. doi: 10.1038/ejcn.2013.296. PubMed DOI

Razavi Zade M., Telkabadi M.H., Bahmani F., Salehi B., Farshbaf S., Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: A randomized clinical trial. Liver Int. 2016;36:563–571. doi: 10.1111/liv.12990. PubMed DOI

Jenkins D.J., Jones P.J., Frohlich J., Lamarche B., Ireland C., Nishi S.K., Srichaikul K., Galange P., Pellini C., Faulkner D., et al. The effect of a dietary portfolio compared to a DASH-type diet on blood pressure. Nutr. Metab. Cardiovasc. Dis. 2015;25:1132–1139. doi: 10.1016/j.numecd.2015.08.006. PubMed DOI

King D.E., Egan B.M., Woolson R.F., Mainous A.G., 3rd, Al-Solaiman Y., Jesri A. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch. Intern. Med. 2007;167:502–506. doi: 10.1001/archinte.167.5.502. PubMed DOI

Roussell M.A., Hill A.M., Gaugler T.L., West S.G., Heuvel J.P., Alaupovic P., Gillies P.J., Kris-Etherton P.M. Beef in an Optimal Lean Diet study: Effects on lipids, lipoproteins, and apolipoproteins. Am. J. Clin. Nutr. 2012;95:9–16. doi: 10.3945/ajcn.111.016261. PubMed DOI PMC

Wang X., Ouyang Y., Liu J., Zhu M., Zhao G., Bao W., Hu F.B. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014;349:g4490. doi: 10.1136/bmj.g4490. PubMed DOI PMC

Tang G., Wang D., Long J., Yang F., Si L. Meta-analysis of the association between whole grain intake and coronary heart disease risk. Am. J. Cardiol. 2015;115:625–629. doi: 10.1016/j.amjcard.2014.12.015. PubMed DOI

Reynolds A.N. Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple? Lancet. 2018;391:1676. doi: 10.1016/S0140-6736(18)30845-6. PubMed DOI

Viguiliouk E., Blanco Mejia S., Kendall C.W., Sievenpiper J.L. Can pulses play a role in improving cardiometabolic health? Evidence from systematic reviews and meta-analyses. Ann. N. Y. Acad. Sci. 2017;1392:43–57. doi: 10.1111/nyas.13312. PubMed DOI PMC

Aune D., Keum N., Giovannucci E., Fadnes L.T., Boffetta P., Greenwood D.C., Tonstad S., Vatten L.J., Riboli E., Norat T. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: A systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016;14:207. doi: 10.1186/s12916-016-0730-3. PubMed DOI PMC

Abete I., Romaguera D., Vieira A.R., Lopez de Munain A., Norat T. Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: A meta-analysis of cohort studies. Br. J. Nutr. 2014;112:762–775. doi: 10.1017/S000711451400124X. PubMed DOI

Wang X., Lin X., Ouyang Y.Y., Liu J., Zhao G., Pan A., Hu F.B. Red and processed meat consumption and mortality: Dose-response meta-analysis of prospective cohort studies. Public Health Nutr. 2016;19:893–905. doi: 10.1017/S1368980015002062. PubMed DOI PMC

Threapleton D.E., Greenwood D.C., Evans C.E., Cleghorn C.L., Nykjaer C., Woodhead C., Cade J.E., Gale C.P., Burley V.J. Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ. 2013;347:f6879. doi: 10.1136/bmj.f6879. PubMed DOI PMC

Arts I.C., Hollman P.C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005;81:317S–325S. doi: 10.1093/ajcn/81.1.317S. PubMed DOI

Perez-Cano F.J., Castell M. Flavonoids, Inflammation and Immune System. Nutrients. 2016;8:659. doi: 10.3390/nu8100659. PubMed DOI PMC

Lim S.S., Vos T., Flaxman A.D., Danaei G., Shibuya K., Adair-Rohani H., Amann M., Anderson H.R., Andrews K.G., Aryee M., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260. doi: 10.1016/S0140-6736(12)61766-8. PubMed DOI PMC

Lewington S., Clarke R., Qizilbash N., Peto R., Collins R., Prospective Studies, Collaboration Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. PubMed

Cholesterol Treatment Trialists Collaboration. Baigent C., Blackwell L., Emberson J., Holland L.E., Reith C., Bhala N., Peto R., Barnes E.H., Keech A., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681. PubMed PMC

Cholesterol Treatment Trialists Collaboration. Fulcher J., O’Connell R., Voysey M., Emberson J., Blackwell L., Mihaylova B., Simes J., Collins R., Kirby A., et al. Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385:1397–1405. PubMed

Cannon C.P., Blazing M.A., Giugliano R.P., McCagg A., White J.A., Theroux P., Darius H., Lewis B.S., Ophuis T.O., Jukema J.W., et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N. Engl. J. Med. 2015;372:2387–2397. doi: 10.1056/NEJMoa1410489. PubMed DOI

Johnston B.C., Kanters S., Bandayrel K., Wu P., Naji F., Siemieniuk R.A., Ball G.D., Busse J.W., Thorlund K., Guyatt G., et al. Comparison of weight loss among named diet programs in overweight and obese adults: A meta-analysis. JAMA. 2014;312:923–933. doi: 10.1001/jama.2014.10397. PubMed DOI

Haslam D.W., James W.P. Obesity. Lancet. 2005;366:1197–1209. doi: 10.1016/S0140-6736(05)67483-1. PubMed DOI

Sotos-Prieto M., Bhupathiraju S.N., Mattei J., Fung T.T., Li Y., Pan A., Willett W.C., Rimm E.B., Hu F.B. Association of Changes in Diet Quality with Total and Cause-Specific Mortality. N. Engl. J. Med. 2017;377:143–153. doi: 10.1056/NEJMoa1613502. PubMed DOI PMC

Li M., Fan Y., Zhang X., Hou W., Tang Z. Fruit and vegetable intake and risk of type 2 diabetes mellitus: Meta-analysis of prospective cohort studies. BMJ Open. 2014;4:e005497. doi: 10.1136/bmjopen-2014-005497. PubMed DOI PMC

Gijsbers L., Ding E.L., Malik V.S., de Goede J., Geleijnse J.M., Soedamah-Muthu S.S. Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 2016;103:1111–1124. doi: 10.3945/ajcn.115.123216. PubMed DOI

Wei G.S., Coady S.A., Goff D.C., Jr., Brancati F.L., Levy D., Selvin E., Vasan R.S., Fox C.S. Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study. Diabetes Care. 2011;34:873–879. doi: 10.2337/dc10-1786. PubMed DOI PMC

Emdin C.A., Anderson S.G., Woodward M., Rahimi K. Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies. J. Am. Coll. Cardiol. 2015;66:1552–1562. doi: 10.1016/j.jacc.2015.07.059. PubMed DOI PMC

Marott S.C., Nordestgaard B.G., Tybjaerg-Hansen A., Benn M. Components of the Metabolic Syndrome and Risk of Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2016;101:3212–3221. doi: 10.1210/jc.2015-3777. PubMed DOI

Post R.E., Mainous A.G., 3rd, King D.E., Simpson K.N. Dietary fiber for the treatment of type 2 diabetes mellitus: A meta-analysis. J. Am. Board Fam. Med. 2012;25:16–23. doi: 10.3122/jabfm.2012.01.110148. PubMed DOI

Evans C.E., Greenwood D.C., Threapleton D.E., Cleghorn C.L., Nykjaer C., Woodhead C.E., Gale C.P., Burley V.J. Effects of dietary fibre type on blood pressure: A systematic review and meta-analysis of randomized controlled trials of healthy individuals. J. Hypertens. 2015;33:897–911. doi: 10.1097/HJH.0000000000000515. PubMed DOI

Hou Q., Li Y., Li L., Cheng G., Sun X., Li S., Tian H. The Metabolic Effects of Oats Intake in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Nutrients. 2015;7:10369–10387. doi: 10.3390/nu7125536. PubMed DOI PMC

Sievenpiper J.L., Kendall C.W., Esfahani A., Wong J.M., Carleton A.J., Jiang H.Y., Bazinet R.P., Vidgen E., Jenkins D.J. Effect of non-oil-seed pulses on glycaemic control: A systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009;52:1479–1495. doi: 10.1007/s00125-009-1395-7. PubMed DOI

Choo V.L., Viguiliouk E., Blanco Mejia S., Cozma A.I., Khan T.A., Ha V., Wolever T.M.S., Leiter L.A., Vuksan V., Kendall C.W.C., et al. Food sources of fructose-containing sugars and glycaemic control: Systematic review and meta-analysis of controlled intervention studies. BMJ. 2018;363:k4644. doi: 10.1136/bmj.k4644. PubMed DOI PMC

InterAct Consortium Dietary fibre and incidence of type 2 diabetes in eight European countries: The EPIC-InterAct Study and a meta-analysis of prospective studies. Diabetologia. 2015;58:1394–1408. doi: 10.1007/s00125-015-3585-9. PubMed DOI PMC

Aune D., Norat T., Romundstad P., Vatten L.J. Whole grain and refined grain consumption and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Eur. J. Epidemiol. 2013;28:845–858. doi: 10.1007/s10654-013-9852-5. PubMed DOI

Kotchen T.A., Kotchen J.M. Dietary sodium and blood pressure: Interactions with other nutrients. Am. J. Clin. Nutr. 1997;65:708S–711S. doi: 10.1093/ajcn/65.2.708S. PubMed DOI

Whelton P.K., He J., Cutler J.A., Brancati F.L., Appel L.J., Follmann D., Klag M.J. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997;277:1624–1632. doi: 10.1001/jama.1997.03540440058033. PubMed DOI

Petrov V., Lijnen P. Modification of intracellular calcium and plasma renin by dietary calcium in men. Am. J. Hypertens. 1999;12:1217–1224. doi: 10.1016/S0895-7061(99)00126-0. PubMed DOI

Kanbay M., Bayram Y., Solak Y., Sanders P.W. Dietary potassium: A key mediator of the cardiovascular response to dietary sodium chloride. J. Am. Soc. Hypertens. 2013;7:395–400. doi: 10.1016/j.jash.2013.04.009. PubMed DOI PMC

Haddy F.J., Vanhoutte P.M., Feletou M. Role of potassium in regulating blood flow and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;290:R546–R552. doi: 10.1152/ajpregu.00491.2005. PubMed DOI

Zacchia M., Abategiovanni M.L., Stratigis S., Capasso G. Potassium: From Physiology to Clinical Implications. Kidney Dis. (Basel) 2016;2:72–79. doi: 10.1159/000446268. PubMed DOI PMC

Siervo M., Lara J., Ogbonmwan I., Mathers J.C. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: A systematic review and meta-analysis. J. Nutr. 2013;143:818–826. doi: 10.3945/jn.112.170233. PubMed DOI

Jayalath V.H., de Souza R.J., Sievenpiper J.L., Ha V., Chiavaroli L., Mirrahimi A., Di Buono M., Bernstein A.M., Leiter L.A., Kris-Etherton P.M., et al. Effect of dietary pulses on blood pressure: A systematic review and meta-analysis of controlled feeding trials. Am. J. Hypertens. 2014;27:56–64. PubMed PMC

Huang H., Chen G., Liao D., Zhu Y., Xue X. Effects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials. Sci. Rep. 2016;6:23625. doi: 10.1038/srep23625. PubMed DOI PMC

Khan K., Jovanovski E., Ho H.V.T., Marques A.C.R., Zurbau A., Mejia S.B., Sievenpiper J.L., Vuksan V. The effect of viscous soluble fiber on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2018;28:3–13. doi: 10.1016/j.numecd.2017.09.007. PubMed DOI

Ho H.V., Sievenpiper J.L., Zurbau A., Blanco Mejia S., Jovanovski E., Au-Yeung F., Jenkins A.L., Vuksan V. The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials. Br. J. Nutr. 2016;116:1369–1382. doi: 10.1017/S000711451600341X. PubMed DOI

Hollaender P.L., Ross A.B., Kristensen M. Whole-grain and blood lipid changes in apparently healthy adults: A systematic review and meta-analysis of randomized controlled studies. Am. J. Clin. Nutr. 2015;102:556–572. doi: 10.3945/ajcn.115.109165. PubMed DOI

Ha V., Sievenpiper J.L., de Souza R.J., Jayalath V.H., Mirrahimi A., Agarwal A., Chiavaroli L., Mejia S.B., Sacks F.M., Di Buono M., et al. Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: A systematic review and meta-analysis of randomized controlled trials. CMAJ. 2014;186:E252–E262. doi: 10.1503/cmaj.131727. PubMed DOI PMC

Hooper L., Martin N., Abdelhamid A., Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst. Rev. 2015 doi: 10.1002/14651858.CD011737. PubMed DOI

Chiavaroli L., Nishi S.K., Khan T.A., Braunstein C.R., Glenn A.J., Mejia S.B., Rahelic D., Kahleova H., Salas-Salvado J., Jenkins D.J.A., et al. Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials. Prog. Cardiovasc. Dis. 2018;61:43–53. doi: 10.1016/j.pcad.2018.05.004. PubMed DOI

Mytton O.T., Nnoaham K., Eyles H., Scarborough P., Ni Mhurchu C. Systematic review and meta-analysis of the effect of increased vegetable and fruit consumption on body weight and energy intake. BMC Public Health. 2014;14:886. doi: 10.1186/1471-2458-14-886. PubMed DOI PMC

Howarth N.C., Saltzman E., Roberts S.B. Dietary fiber and weight regulation. Nutr. Rev. 2001;59:129–139. doi: 10.1111/j.1753-4887.2001.tb07001.x. PubMed DOI

Kim S.J., de Souza R.J., Choo V.L., Ha V., Cozma A.I., Chiavaroli L., Mirrahimi A., Blanco Mejia S., Di Buono M., Bernstein A.M., et al. Effects of dietary pulse consumption on body weight: A systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2016;103:1213–1223. doi: 10.3945/ajcn.115.124677. PubMed DOI

Li S.S., Kendall C.W., de Souza R.J., Jayalath V.H., Cozma A.I., Ha V., Mirrahimi A., Chiavaroli L., Augustin L.S., Blanco Mejia S., et al. Dietary pulses, satiety and food intake: A systematic review and meta-analysis of acute feeding trials. Obesity (Silver Spring) 2014;22:1773–1780. doi: 10.1002/oby.20782. PubMed DOI

Oh S.W., Han K.H., Han S.Y., Koo H.S., Kim S., Chin H.J. Association of Sodium Excretion With Metabolic Syndrome, Insulin Resistance, and Body Fat. Medicine (Baltimore) 2015;94:e1650. doi: 10.1097/MD.0000000000001650. PubMed DOI PMC

Jiao J., Xu J.Y., Zhang W., Han S., Qin L.Q. Effect of dietary fiber on circulating C-reactive protein in overweight and obese adults: A meta-analysis of randomized controlled trials. Int. J. Food Sci. Nutr. 2015;66:114–119. doi: 10.3109/09637486.2014.959898. PubMed DOI

Estruch R., Martinez-Gonzalez M.A., Corella D., Basora-Gallisa J., Ruiz-Gutierrez V., Covas M.I., Fiol M., Gomez-Gracia E., Lopez-Sabater M.C., Escoda R., et al. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J. Epidemiol. Community Health. 2009;63:582–588. doi: 10.1136/jech.2008.082214. PubMed DOI

Kanauchi O., Mitsuyama K., Araki Y., Andoh A. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr. Pharm Des. 2003;9:333–346. doi: 10.2174/1381612033391883. PubMed DOI

Scheppach W., Wiggins H.S., Halliday D., Self R., Howard J., Branch W.J., Schrezenmeir J., Cummings J.H. Effect of gut-derived acetate on glucose turnover in man. Clin. Sci. (Lond.) 1988;75:363–370. doi: 10.1042/cs0750363. PubMed DOI

Lee Y., Kang D., Lee S.A. Effect of dietary patterns on serum C-reactive protein level. Nutr. Metab. Cardiovasc. Dis. 2014;24:1004–1011. doi: 10.1016/j.numecd.2014.05.001. PubMed DOI

Watzl B., Kulling S.E., Moseneder J., Barth S.W., Bub A. A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am. J. Clin. Nutr. 2005;82:1052–1058. doi: 10.1093/ajcn/82.5.1052. PubMed DOI

Dibaba D.T., Xun P., He K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: Meta-analysis and systematic review. Eur. J. Clin. Nutr. 2014;68:971. doi: 10.1038/ejcn.2014.111. PubMed DOI

Almoznino-Sarafian D., Berman S., Mor A., Shteinshnaider M., Gorelik O., Tzur I., Alon I., Modai D., Cohen N. Magnesium and C-reactive protein in heart failure: An anti-inflammatory effect of magnesium administration? Eur. J. Nutr. 2007;46:230–237. doi: 10.1007/s00394-007-0655-x. PubMed DOI

Chen X., Touyz R.M., Park J.B., Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 2001;38:606–611. doi: 10.1161/hy09t1.094005. PubMed DOI

Yang Y., Gao M., Nie W., Yuan J., Zhang B., Wang Z., Wu Z. Dietary magnesium sulfate supplementation protects heat stress-induced oxidative damage by restoring the activities of anti-oxidative enzymes in broilers. Biol. Trace Elem. Res. 2012;146:53–58. doi: 10.1007/s12011-011-9210-y. PubMed DOI

Blanco Mejia S., Kendall C.W., Viguiliouk E., Augustin L.S., Ha V., Cozma A.I., Mirrahimi A., Maroleanu A., Chiavaroli L., Leiter L.A., et al. Effect of tree nuts on metabolic syndrome criteria: A systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2014;4:e004660. doi: 10.1136/bmjopen-2013-004660. PubMed DOI PMC

Ho H.V., Sievenpiper J.L., Zurbau A., Blanco Mejia S., Jovanovski E., Au-Yeung F., Jenkins A.L., Vuksan V. A systematic review and meta-analysis of randomized controlled trials of the effect of barley beta-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction(i-iv) Eur. J. Clin. Nutr. 2016;70:1340. doi: 10.1038/ejcn.2016.129. PubMed DOI

Health Promotion and Disease Prevention: Fruit and Vegetables European Commission. [(accessed on 28 November 2018)]; Available online: https://ec.europa.eu/jrc/en/health-knowledge-gateway/promotion-prevention/nutrition/fruit-vegetables#_jrc2018.

Health Promotion and Disease Prevention: Dietary Fats European Commission. [(accessed on 28 November 2018)]; Available online: https://ec.europa.eu/jrc/en/health-knowledge-gateway/promotion-prevention/nutrition/fats#_Toctb5b.

Hjartaker A., Lagiou A., Slimani N., Lund E., Chirlaque M.D., Vasilopoulou E., Zavitsanos X., Berrino F., Sacerdote C., Ocke M.C., et al. Consumption of dairy products in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: Data from 35,955 24-hour dietary recalls in 10 European countries. Public Health Nutr. 2002;5:1259–1271. doi: 10.1079/PHN2002403. PubMed DOI

Lee-Kwan S.H., Moore L.V., Blanck H.M., Harris D.M., Galuska D. Disparities in State-Specific Adult Fruit and Vegetable Consumption—United States, 2015. MMWR Morb. Mortal Wkly. Rep. 2017;66:1241–1247. doi: 10.15585/mmwr.mm6645a1. PubMed DOI PMC

U. S. Department of Agricultural Service Food Patterns Equivalents Intakes from Food: Mean Amounts Consumed per Individual, by Gender and Age, What We Eat In America, NHANES 2009–2010. [(accessed on 27 November 2018)];2013 Available online: www.ars.usda.gov/ba/bhnrc/fsrg.

Nielsen S.J., Kit B.K., Ogden C.L. Nut Consumption Among U.S. Adults, 2009–2010. NCHS Data Brief. 2014;176:1–8. PubMed

Combination of Multiple Low-Risk Lifestyle Behaviors and Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies

Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Dietary Patterns and Cardiometabolic Outcomes in Diabetes: A Summary of Systematic Reviews and Meta-Analyses